SOFTGEL CAPSULE
MANUFACTURER INDIA
FOR SOUTH AFRICA
WHO-GMP certified softgel capsules from Haryana, India — serving South African importers with SAHPRA-ready documentation, competitive pricing, Halal certification, and flexible order volumes.
SOUTH AFRICA'S PHARMACEUTICAL IMPORT LANDSCAPE
South Africa is the largest African market for Indian pharmaceutical exports — with approximately $669 million in pharma imports from India annually. This dominant trade relationship reflects South Africa's position as the most developed pharmaceutical market on the African continent, with sophisticated retail pharmacy chains, a robust private healthcare infrastructure, and a regulatory framework that is among the most rigorous in Africa.
With a population of 60 million, South Africa has the highest per-capita pharmaceutical expenditure in Sub-Saharan Africa. The country's dual healthcare system — a well-resourced private sector alongside a public healthcare network serving the majority of the population — creates demand across both premium pharmacy retail (Dis-Chem, Clicks) and institutional channels (government hospitals, community health centres). South Africa's National Health Insurance (NHI) initiative is expected to further expand access to essential medicines and health products across the country.
The South African Health Products Regulatory Authority (SAHPRA) regulates all pharmaceutical and health product imports. SAHPRA is considered one of the strictest regulatory authorities in Africa — stricter than most other African countries. The registration process requires GMP compliance verification, CTD-format dossier submission, Certificate of Pharmaceutical Product (WHO format) from CDSCO India, product quality testing, and import permits including Form GW 12/44. Indian manufacturers with WHO-GMP certification have a recognized pathway through this regulatory framework, but the bar is high.
South Africa's disease burden is dominated by non-communicable diseases — cardiovascular disease, diabetes, hypertension, and cancer account for 51% of all deaths. Simultaneously, the country faces a significant HIV/AIDS and tuberculosis burden that drives ongoing pharmaceutical demand. This dual disease burden creates sustained demand for both prescription medications and nutraceutical supplements: Omega-3 for cardiovascular health, Vitamin D3 for immune support and bone health, multivitamins for micronutrient deficiency, and antioxidant formulations for preventive health — all areas where softgel capsule delivery is preferred by South African consumers and healthcare providers.
SAHPRA REGISTRATION PROCESS
The South African Health Products Regulatory Authority (SAHPRA) regulates all pharmaceutical and health product imports into South Africa. The registration process requires a local responsible pharmacist, CTD dossier, GMP verification, quality testing, and import permits.
- 01
Appoint a South African responsible pharmacist
SAHPRA requires all imported pharmaceutical and health products to be represented by a locally registered responsible pharmacist or authorized importer. The South African entity must hold appropriate licenses from the South African Pharmacy Council and is responsible for the product registration application, SAHPRA correspondence, pharmacovigilance obligations, and post-market surveillance. This local partnership is mandatory before any product registration can proceed.
- 02
Manufacturer GMP compliance verification
SAHPRA conducts rigorous GMP compliance assessment of foreign manufacturing facilities as part of the product registration process. This may include a desk review of GMP documentation or an on-site inspection of the manufacturing facility by SAHPRA inspectors. Our WHO-GMP certification provides a strong foundation for this assessment. Admetus welcomes and facilitates SAHPRA inspection visits to our Jind, Haryana facility when required, with all documentation prepared in English.
- 03
Submit CTD-format registration dossier
SAHPRA follows the CTD (Common Technical Document) format for product registration — aligned with international ICH guidelines. The dossier includes five modules covering administrative information, quality (chemistry, manufacturing, controls), safety data, efficacy information, and product labeling compliant with South African requirements. Admetus prepares the complete Module 3 (Quality) documentation including manufacturing process validation, analytical methods, stability data under ICH Zone IVa conditions, and Certificate of Analysis templates.
- 04
Provide Certificate of Pharmaceutical Product (WHO format)
SAHPRA requires a Certificate of Pharmaceutical Product (CPP) in WHO format issued by the Central Drugs Standard Control Organisation (CDSCO) of India. The CPP confirms that the product is registered, manufactured under GMP conditions, and freely sold in the country of origin. Admetus coordinates the CPP application with CDSCO and provides the authenticated certificate as part of the registration package.
- 05
Product quality testing and evaluation
SAHPRA requires laboratory analysis of product samples at approved testing facilities in South Africa. Testing covers identity, assay, dissolution, microbial limits, heavy metals, and compliance with pharmacopoeial specifications (South African Pharmacopoeia, BP, or USP). We provide the required sample quantities with full Certificate of Analysis documentation to facilitate the laboratory evaluation process.
- 06
Import permit via SAHPRA and SARS customs
Once product registration is approved, each import shipment requires documentation for clearance through the South African Revenue Service (SARS) customs system. The importer must obtain the necessary import permits from SAHPRA — including Form GW 12/44 for pharmaceutical products — and ensure HSN code compliance for correct tariff classification. The South African importer's clearing agent processes the customs documentation with the export paperwork we provide — commercial invoice, packing list, COA, and SAHPRA registration evidence.
SOUTH AFRICA — GATEWAY TO SOUTHERN AFRICA
South Africa's Durban port is the largest and busiest port in Sub-Saharan Africa. Pharmaceutical imports entering through Durban are distributed not only across South Africa's nine provinces but also to neighbouring countries in the Southern African Development Community (SADC) region — including Mozambique, Botswana, Namibia, Zimbabwe, Zambia, and eSwatini. This makes South Africa the strategic hub for any Indian manufacturer targeting the Southern African market.
The SADC region — comprising 16 member states with a combined population exceeding 380 million — benefits from preferential trade agreements that facilitate cross-border pharmaceutical distribution. South African pharmaceutical distributors have established supply chains and regulatory relationships across the region, making a South African import partnership the most efficient entry point for the broader Southern African market.
For Admetus, this means that a single South African import partnership is not just a South African opportunity — it is a Southern African opportunity. We support importers who are positioning softgel capsule distribution across the broader SADC region, with documentation and pricing structured for multi-market supply.
WHY SOUTH AFRICAN IMPORTERS CHOOSE US
WHO-GMP certification aligned with SAHPRA requirements
The South African Health Products Regulatory Authority (SAHPRA) requires foreign pharmaceutical manufacturers to demonstrate GMP compliance as part of the product registration process. Admetus holds WHO-GMP certification for its Jind, Haryana facility, which aligns with SAHPRA's GMP expectations and facilitates the regulatory dossier review. WHO-GMP status is a critical baseline for any Indian manufacturer seeking to supply the South African market.
Africa's largest pharmaceutical import market from India
South Africa imports approximately $669 million in pharmaceutical products from India annually, making it the single largest African destination for Indian pharma exports. This established trade corridor means well-developed logistics infrastructure, experienced customs brokers, and a regulatory framework that Indian manufacturers can navigate with proper documentation. Admetus leverages this mature India-South Africa pharma trade relationship to ensure efficient market entry for our softgel capsule range.
Five international certifications including Halal
Beyond WHO-GMP, our facility holds FSSAI, GMP, HACCP, and Halal certifications. South Africa has a significant Muslim population — approximately 2-3% of the total population concentrated in the Western Cape and KwaZulu-Natal provinces. Halal certification is important for distribution in these regions and positions our products for broader Southern African markets with Muslim populations including Mozambique and Tanzania.
Competitive pricing for the South African market
South Africa is a sophisticated pharmaceutical market where importers evaluate landed cost, quality, and reliability together. Our Haryana facility operates with lower overhead than manufacturers in Mumbai, Hyderabad, or Ahmedabad, allowing competitive CIF Durban/Cape Town pricing. Combined with South Africa's trade agreements and tariff structures for pharmaceutical imports, our pricing enables South African distributors to maintain healthy retail margins across pharmacy and institutional channels.
Flexible MOQ for market entry and registration
We understand that South African importers — particularly those registering new products with SAHPRA — need flexibility in initial order sizes. We support pilot-volume orders for SAHPRA sample submission and market testing, with the ability to scale to full-container loads once product registration and market demand are established. This is particularly valuable for importers expanding into new therapeutic categories or building distribution networks across Southern Africa.
SOFTGEL FORMULATIONS FOR THE SOUTH AFRICAN MARKET
Cholecalciferol (Vitamin D3) 60,000 IU
Vitamin D deficiency is a documented health concern in South Africa, particularly among darker-skinned populations and urban dwellers with limited sun exposure despite the country's sunny climate. South African healthcare providers increasingly prescribe high-dose Vitamin D3 for deficiency treatment, immune support, and bone health. The 60,000 IU softgel format is preferred for therapeutic loading doses, with weekly dosing protocols becoming standard in South African clinical practice — particularly for patients with confirmed deficiency via blood testing.
Omega-3 Fatty Acids + Vitamin E
Non-communicable diseases are the leading cause of death in South Africa, with cardiovascular disease, diabetes, and hypertension affecting millions. The WHO estimates that NCDs account for 51% of all deaths in South Africa — one of the highest rates on the African continent. Omega-3 softgel capsules are widely recommended by South African healthcare providers and are available through pharmacy retail chains including Dis-Chem, Clicks, and independent pharmacies across all nine provinces.
Multivitamin Softgel Capsules
Micronutrient deficiency remains a significant health challenge in South Africa despite being an upper-middle-income country. Iron, zinc, Vitamin A, and folate deficiencies are widespread, particularly in rural areas and among lower-income populations. Multivitamin softgel capsules serve both the retail pharmacy market (Dis-Chem, Clicks, independent pharmacies) and institutional channels (government health programs, corporate wellness initiatives). South Africa's National Health Insurance rollout is expected to expand access to essential nutritional supplements.
Antioxidant Formulations (Lycopene + Grape Seed Extract)
South Africa has a well-developed wellness and preventive health market, driven by a health-conscious urban middle class and high NCD burden. Antioxidant formulations targeting cardiovascular protection, immune support, and prostate health (Lycopene) have established demand in South Africa's pharmacy retail market. The country's sophisticated consumer base understands preventive supplementation, making it one of Africa's most receptive markets for advanced nutraceutical formulations.
Calcitriol + Calcium Citrate + Vitamin K2-7
Bone health formulations serve South Africa's aging population and women's health segment. Osteoporosis is increasingly recognized as a significant health concern, particularly among post-menopausal women and the elderly. South Africa's orthopedic and endocrinology specialists regularly prescribe calcium-vitamin D-K2 combinations. The country's well-developed private healthcare infrastructure (Mediclinic, Netcare, Life Healthcare) supports specialist-driven prescribing of advanced bone health formulations.
We manufacture 10+ standard softgel formulations with custom formulation development on request. All products can be supplied under your brand name for the South African and Southern African market. See our complete product catalog and private label service for full details.
DOCUMENTATION FOR SAHPRA & CUSTOMS
Certificate of Analysis (COA)
Batch-specific quality certificate covering identity testing, assay, dissolution, microbial limits, heavy metals, and physical parameters. Required by SAHPRA for product registration and by South African importers for each shipment's SARS customs clearance at Durban or Cape Town port.
Certificate of Pharmaceutical Product (WHO Format)
Issued by India's CDSCO in WHO format, the CPP confirms that the product is registered, manufactured under GMP conditions, and freely sold in India. SAHPRA requires a WHO-format CPP as part of the product registration dossier. Admetus coordinates the CPP application with CDSCO.
WHO-GMP Certificate
World Health Organization Good Manufacturing Practice certificate for the manufacturing facility. SAHPRA requires GMP compliance as baseline evidence of manufacturing quality — this certificate is a key document in the SAHPRA registration dossier and supports the GMP compliance assessment process.
CTD-Format Quality Dossier (Module 3)
The Common Technical Document Module 3 (Quality) section includes manufacturing process description, validation data, analytical method details, stability study results under ICH Zone IVa conditions, and product specifications. Admetus prepares this module for the South African importer to include in their SAHPRA registration submission.
Halal Certificate
Halal certification for the manufacturing facility and specific products. Important for distribution to South Africa's Muslim communities concentrated in the Western Cape (Cape Town) and KwaZulu-Natal (Durban) provinces. Also essential for cross-border trade to Mozambique, Tanzania, and other Southern/East African markets with significant Muslim populations.
Commercial Invoice & Packing List
Detailed commercial invoice with FOB/CIF Durban or Cape Town pricing, HS codes, South African tariff classifications, and payment terms. Packing list with batch numbers, quantities, net/gross weights, and container loading details. Required by South African Revenue Service (SARS) for import duty assessment and customs clearance. Form GW 12/44 compliance documentation included.
INDIA TO SOUTH AFRICA SHIPPING ROUTE
The India-South Africa shipping corridor is one of the busiest pharmaceutical trade routes between Asia and Africa, with regular container vessel services from Mumbai to Durban and Cape Town.
- 01
Origin: JNPT (Mumbai)
Products are dispatched from our Jind, Haryana facility to JNPT port in Mumbai (approximately 1,200km by road, 2-3 days transit). JNPT is India's largest container port and has regular services to South African ports. Cargo is consolidated, inspected, and cleared for export at the port's pharmaceutical cargo handling facilities.
- 02
Sea freight: India to Durban / Cape Town
Container vessel services from JNPT to Durban operate on regular schedules with 14-18 days ocean transit time. Durban — located on South Africa's east coast — is the largest port in Africa and the primary destination for pharmaceutical imports. Cape Town port serves as an alternative for Western Cape distribution. Multiple shipping lines serve the India-South Africa route with weekly departures, ensuring consistent supply chain reliability.
- 03
Destination: Durban or Cape Town Port
Pharmaceutical imports arrive at Durban — the largest port in Sub-Saharan Africa — or Cape Town. South African Revenue Service (SARS) customs clearance and SAHPRA verification are processed through the customs system, typically taking 3-7 business days. The importer's clearing agent handles port-side clearance with the documentation package we provide. From Durban, cargo is distributed to Johannesburg (approximately 600km via the N3 highway), Pretoria, and across the country's logistics network.
- 04
Packaging for transit
All South Africa-bound shipments are packed in pharmaceutical-grade export packaging — blister packs or bottles in outer cartons, master cartons with desiccants, tamper-evident sealing, and batch identification. Packaging is designed for ocean transit conditions and South Africa's varied climate zones. We coordinate with the buyer's freight forwarder or recommend trusted logistics partners for the India-South Africa corridor.
SOUTH AFRICA EXPORT Q&A
01What is the SAHPRA registration process for importing softgels to South Africa?
The South African Health Products Regulatory Authority (SAHPRA) regulates all pharmaceutical and health product imports into South Africa. The registration process involves: appointing a local responsible pharmacist or authorized importer, submitting a CTD-format registration dossier, providing a WHO-GMP certificate and Certificate of Pharmaceutical Product (WHO format) from CDSCO India, undergoing GMP compliance verification (desk review or on-site inspection), and submitting product samples for laboratory analysis. Import permits including Form GW 12/44 are required for pharmaceutical products. SAHPRA registration is among the most rigorous in Africa. Admetus provides the complete manufacturer documentation package for SAHPRA registration.
02What documentation does Admetus provide for South African import?
We provide the complete manufacturer documentation package for SAHPRA registration: Certificate of Analysis (batch-specific), WHO-GMP certificate, coordination for Certificate of Pharmaceutical Product (WHO format) from CDSCO, CTD Module 3 quality dossier (manufacturing process, validation, analytical methods, stability data for ICH Zone IVa), product specifications, Halal certificate, HSN code compliance documentation, and commercial export documents (invoice, packing list, HS codes, South African tariff classifications). We also provide product samples for SAHPRA laboratory evaluation upon request.
03What is the MOQ for South Africa export orders?
MOQs are flexible and depend on the formulation, packaging format, and order configuration. For initial orders — particularly those tied to SAHPRA registration and market testing — we offer pilot volumes. Once SAHPRA registration is secured and market demand is established, we support full 20ft and 40ft container loads for ongoing supply. Specific MOQ and pricing are confirmed within 48 hours of inquiry at [email protected].
04How long does shipping take from India to South Africa?
Sea freight from JNPT (Mumbai) to Durban takes approximately 14-18 days ocean transit time. Durban is South Africa's largest and busiest port, handling the majority of the country's container traffic including pharmaceutical imports. Cape Town port is an alternative destination for Western Cape distribution. After port arrival, SARS customs clearance typically takes 3-7 business days depending on documentation completeness and SAHPRA verification. Total transit from factory dispatch to warehouse delivery is typically 25-35 days.
05Why is South Africa the largest African market for Indian pharma?
South Africa imports approximately $669 million in pharmaceutical products from India annually — the largest volume of any African country. This is driven by several factors: South Africa has the most developed pharmaceutical market in Africa with sophisticated retail pharmacy chains (Dis-Chem, Clicks), a high NCD burden requiring ongoing medication and supplementation, well-established India-South Africa trade corridors, and a regulatory framework (SAHPRA) that, while rigorous, provides a clear pathway for WHO-GMP certified manufacturers. South Africa's position also makes it a gateway to the broader Southern African Development Community (SADC) region.
06Is Admetus Halal certified for the South African market?
Yes. Admetus Lifesciences holds Halal certification for its manufacturing facility and product range. South Africa has a significant Muslim population concentrated in the Western Cape (Cape Town — largest Muslim community in South Africa) and KwaZulu-Natal (Durban) provinces. Halal certification is essential for distribution through halal-focused retailers and pharmacies serving these communities. Additionally, Halal certification supports cross-border distribution from South Africa to neighboring countries with Muslim populations. All our softgel formulations can be supplied with Halal certification documentation.
START YOUR SOUTH AFRICA EXPORT ORDER
Contact our export team to discuss your South Africa and Southern Africa import requirements — SAHPRA documentation, formulation selection, MOQ, pricing, and shipping to Durban. We respond within 48 hours.